John H. Leaman - 12 Dec 2025 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Role
Director
Signature
/s/ John Leaman
Issuer symbol
TRAW
Transactions as of
12 Dec 2025
Net transactions value
$0
Form type
4
Filing time
16 Dec 2025, 18:23:54 UTC
Previous filing
25 Nov 2025
Next filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Leaman John Harold Director C/O TRAWS PHARMA, INC., 12 PENNS TRAIL, NEWTON /s/ John Leaman 16 Dec 2025 0001586657

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRAW Common Stock Award $0 +4,058 $0.000000 4,058 12 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRAW Stock Option (right to purchase) Award $0 +16,234 $0.000000 16,234 12 Dec 2025 Common Stock 16,234 $2.33 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units that will vest 100% on the first anniversary of the grant date. Each restricted stock unit will convert into shares of common stock on a one-for-one basis.
F2 The options vest 100% on the first anniversary of the grant date.